Welcome to our dedicated page for Hoth Therapeutics SEC filings (Ticker: HOTH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Hoth Therapeutics, Inc. SEC filings document a clinical-stage biopharmaceutical issuer’s material events, capital structure actions, governance arrangements and listing compliance matters. Recent 8-K disclosures cover registered direct offerings of common stock, private-placement warrants, use of a Form S-3 shelf registration, and at-the-market offering prospectus supplements.
The filing record also includes Regulation FD and other-event disclosures for management presentation materials about the therapeutics pipeline and weight-loss drug program, executive employment agreement information, Nasdaq minimum bid price compliance notices, and the formation of Rocket One Inc., a wholly owned subsidiary formed to acquire, own and operate space-industry assets, including nano rocket systems for nanosatellite deployment.
Rocket One Inc. filed a Form 8-K to announce the appointment of retired Major General Malcolm B. Frost to its Space and Defense Advisory Board. He will advise on technical development of infrastructure for the orbital economy, including AI computing and memory hardware for space and defense environments.
The press release highlights General Frost’s nearly 40 years of military and national security experience, including 31 years in the U.S. Army and senior operational and communications roles worldwide. Rocket One describes its strategy around nanomagnetic AI chip technology, radiation-tolerant computing, and space and defense applications, while continuing to advance its biotechnology programs through a subsidiary.
Rocket One Inc. disclosed that it has increased the maximum aggregate offering price of its common stock available under its at-the-market sales agreement with H.C. Wainwright & Co., LLC by up to an additional $6,829,000. This ATM program allows the company to issue and sell shares of common stock from time to time into the market. The company also noted that approximately $9,279,067 of common stock had already been sold under this agreement before the increase and that it filed a new prospectus supplement and related legal opinion to cover the expanded capacity.
Rocket One Inc. amends its prior prospectus supplements to increase the amount available for sale under its Sales Agreement with H.C. Wainwright & Co., LLC. This Amendment No. 2 makes available up to an additional $6,829,000 of common stock for sale pursuant to the Sales Agreement dated November 8, 2024.
The filing states that the company previously offered and sold 8,124,155 shares for gross proceeds of approximately $9.27 million under the Sales Agreement. It reports 22,322,326 shares outstanding and a public float market value held by non-affiliates of $48,326,580 based on 21,768,730 shares held by non-affiliates at a closing price of $2.22 per share on June 2, 2026. The prospectus cites eligibility under General Instruction I.B.6 of Form S-3 to offer up to approximately $6,829,000 in additional shares.
Rocket One Inc. announced the appointment of Dr. Supriyo Bandyopadhyay as Lead Technical Advisor of AI Nanomagnetic Technology. He will guide development of Rocket One’s nanomagnetic AI chip platform, aimed at radiation-tolerant, ultra-low-power computing and memory hardware for space and defense environments.
The filing reiterates Rocket One’s focus on infrastructure for the orbital economy and its exclusive rights to a nanomagnetic matrix multiplier architecture. It also highlights significant risks, including early-stage technology, long development timelines, substantial capital needs, competition, licensing obligations, and regulatory and export-control risks tied to defense and space applications.
Rocket One Inc. director Wayne Linsley received an equity award in the form of stock options. On May 26, 2026, he was granted 75,000 options to acquire common stock at an exercise price of $0.7083 per share.
The options were issued under the company’s Amended and Restated 2022 Omnibus Equity Incentive Plan and vested in full upon grant, meaning they became fully exercisable immediately. Following this award, Linsley holds 75,000 options directly, with an expiration date of May 26, 2036. This filing reflects a compensation-related grant, not an open-market purchase or sale of Rocket One shares.
Rocket One Inc. reported that CEO and President Robb Knie received a grant of stock options as compensation. He was awarded 550,000 options to purchase Rocket One common stock at an exercise price of $0.7083 per share. The options were issued under the company’s Amended and Restated 2022 Omnibus Equity Incentive Plan and vested in full upon grant on May 26, 2026. They are scheduled to expire on May 26, 2036. Following this award, Knie holds 550,000 options directly, giving him the right to acquire an equal number of common shares in the future but involving no open-market buying or selling.
Rocket One Inc. director David Sarnoff received a grant of 75,000 stock options as compensation. These options were awarded at an exercise price of $0.7083 per share and relate to 75,000 shares of common stock. The grant was made under Rocket One Inc.’s Amended and Restated 2022 Omnibus Equity Incentive Plan.
The options vested in full on the grant date, meaning Sarnoff’s right to exercise them is fully earned immediately, and they are scheduled to expire on May 26, 2036. Following this grant, he directly holds 75,000 options, with no open-market share purchases or sales reported in this filing.
Rocket One Inc. director Christopher Michael Camarra received an award of options covering 75,000 shares of common stock. The options have an exercise price of $0.7083 per share, vest in full immediately upon grant, and expire on May 26, 2036. Following this grant, he holds 75,000 options directly.
Rocket One Inc. director Jeff Pavell received a grant of stock options that give him the right to acquire 75,000 shares of Common Stock. The options have an exercise price of $0.7083 per share and expire on May 26, 2036.
The options were issued under the Rocket One Inc. Amended and Restated 2022 Omnibus Equity Incentive Plan and vested in full upon grant, meaning they are immediately exercisable. Following this grant, Pavell holds 75,000 options directly.
Rocket One Inc. increased the maximum aggregate offering price of common stock issuable under its at-the-market Sales Agreement with H.C. Wainwright by up to $2,661,176, and filed a related prospectus supplement along with a legal opinion covering these shares.
The company also announced acceptance into the AMD AI Developer Program, gaining access to cloud resources, tools, and training to support simulation and modeling of its nanomagnetic and spintronic semiconductor technologies for AI, defense, and space applications.